10 Results for "

A427 cells

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "A427 cells" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-125905
CAS No.: 2306193-99-5
Purity:  99.92%
Synonyms: VHL ligand 3; E3 ligase Ligand 19
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

VH032-cyclopropane-F is the VH032-based VHL ligand. VH032-cyclopropane-F can be connected to the ligand for protein (e.g., SMARCA BD ligand) by a linker to form PROTACs (e.g., PROTAC 1). PROTAC 1 is a partial degrader of SMARCA2 and SMARCA4 .
loading...
    loading...
Cat. No.: HY-163697
CAS No.: 2924006-98-2
Target:  

Wee1 Apoptosis

Research Areas:  

Cancer

WEE1-IN-7 (compound 12h) is a potent and orally activeWEE1 inhibitor with an IC50 value of 2.1 nM. WEE1-IN-7 induces apoptosis and cell cycle arrest at the S phase. WEE1-IN-7 shows antitumor activity .
loading...
    loading...
Cat. No.: HY-163064
CAS No.: 2922675-91-8
Target:  

Molecular Glues LRRK2

Research Areas:  

Cancer

CC-3240 (compound 13) is a molecular glue degrader of CaMKK2 based on CC-8977, with the IC50 of 9 nM .
loading...
    loading...
Cat. No.: HY-153674
Target:  

PROTACs SOS1

Research Areas:  

Cancer

PROTAC SOS1 degrader-4 (Compound 10) is a PROTAC degrader that targets the SOS1 protein for degradation by recruiting cereblon. It degrades SOS1 in NCI-H358, A-427, SW-620, and DLD-1 cells and inhibits the proliferation of various KRAS-mutant tumor cells, making it a useful tool for cancer research .
loading...
    loading...
Cat. No.: HY-178010
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

Mcl-1-IN-17 (Compound 25) is an orally active Myeloid Cell Leukemia 1 (Mcl-1) inhibitor with a Ki < 0.08  nM. Mcl-1-IN-17 has a significant antiproliferative activity (GI50s of 39 and 105  nM for H929 and A427 cells, respectively) and inhibits cell apoptosis. Mcl-1-IN-17 can be used for hematological and solid cancers research .
loading...
    loading...
Cat. No.: HY-178008
Research Areas:  

Cancer

Mcl-1-IN-16 is an effective macrocyclic myeloid cell leukemia 1 (Mcl-1) inhibitor with a Ki of below 0.08 nM. Mcl-1-IN-16 maintains high selectivity (>50,000-fold) for Mcl-1 over other antiapoptotic Bcl-2 family members Bcl-2 and Bcl-xL. Mcl-1-IN-16 leads to the activation of caspase-3/7, thereby initiating cell apoptosis. Mcl-1-IN-16 achieves tumor regression in a lung cancer-derived tumor xenograft mice model. Mcl-1-IN-16 can be used in the research of solid tumor such as nonsmall cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-168180
CAS No.: 2975172-98-4
Target:  

Wee1

Research Areas:  

Cancer

WEE1-IN-11 (Compound 13) is a potent CDK2 inhibitor with an IC50 of 2.0 nM. WEE1-IN-11 inhibits NCI–H446, A427, OVCAR3, C33A,and WiDr cells with IC50s of 93.9, 34.5, 86.7, 23.1, and 85 nM, respectively .
loading...
    loading...
Cat. No.: HY-175575
CAS No.: 3027979-08-1
Research Areas:  

Cancer

SOS1 ligand-2 is a SOS1 ligand that can be used for PROTAC synthesis. SOS1 ligand-2 serves as the target protein ligand for PROTAC SOS1 degrader-4 (HY-153674). SOS1 ligand-2 is applicable to the research of KRAS-mutant cancers .
loading...
    loading...
Cat. No.: HY-180200
CAS No.: 3032602-44-8
Target:  

Ras ERK

Research Areas:  

Cancer

RNK08954 is an orally active KRASG12D inhibitor with a Kd of 0.0395 nM. RNK08954 selectively binds the inactive GDP-bound KRASG12D form, suppresses downstream KRAS-mediated signaling pathways p-ERK1/2 experssion. RNK08954 inhibits KRASG12D-mutant cell proliferation, induces G0-G1 cell cycle arrest, and inhibits tumor growth in mouse xenograft models. RNK08954 can be used for the research of non-small cell lung cancer, pancreatic ductal adenocarcinoma .
loading...
    loading...
Cat. No.: HY-182264
CAS No.: 180634-64-4
Synonyms: Nordihydroguaiaretic acid tetrapivalate
Research Areas:  

Cancer

Masoprocol tetrapivalate (Nordihydroguaiaretic acid tetrapivalate) is a catecholic butane metabolite and also a tyrosine kinase activity inhibitor of IGF-1R and EGFR. Masoprocol tetrapivalate regulates tyrosine kinase signaling pathways associated with cell proliferation. Masoprocol tetrapivalate can be used in the research of proliferative diseases, including malignant, precancerous or benign cancers, and solid tumors .
loading...
    loading...